Prime Vector Technologies GmbH - 09/04/2020 A modular brick system for developing a COVID-19 vaccine Prime Vector Technologies GmbH (PVT), a start-up company based in Tübingen in southern Germany, uses a modular brick system to develop vaccines against cancer and infectious diseases. The PVT team is currently working flat out to develop a COVID-19 vaccine.https://www.gesundheitsindustrie-bw.de/en/article/news/mit-einem-impfstoffbaukasten-gegen-covid-19
Article - 21/07/2016 New anticancer drugs – hop compounds have the potential to treat cancer Secondary hop compounds appear to have a positive effect on the immune system and therefore have the potential to be used for the treatment and prevention of cancer. However, the bioavailability of hop compounds in the human body is relatively poor. Researchers from Hohenheim and Tübingen are therefore looking for a way to increase their absorption rate.https://www.gesundheitsindustrie-bw.de/en/article/news/new-drugs-for-the-treatment-of-cancer-hop-compounds-have-the-potential-to-treat-cancer
Article - 02/03/2015 EU supports biophysicists from Ulm to elucidate the structure of chromatin Human DNA consists of three billion base pairs, which corresponds to a total length of approximately two metres. DNA must be compressed 200,000-fold in order to fit into the tiny nuclei of mammalian cells. The thread-like complex of DNA and proteins is called chromatin. Although chromatin has been widely studied, relatively little is yet known about the spatial and temporal organisation of chromatin in interphase cells.https://www.gesundheitsindustrie-bw.de/en/article/news/eu-supports-biophysicists-from-ulm-to-elucidate-the-structure-of-chromatin
Article - 19/01/2015 Kay Gottschalk and the physics of cells You learn a great deal about the physical aspects of cells when you talk to Prof. Dr. Kay-E. Gottschalk. For example, their ability to react as solid and liquid, to adapt their environment to suit themselves and to exert and respond to forces. The 42-year-old has great respect for the smallest of living units, i.e. cells, which he calls smart composite materials. Working on the boundaries of medicine, biology, chemistry and physics, Gottschalk…https://www.gesundheitsindustrie-bw.de/en/article/news/kay-gottschalk-and-the-physics-of-cells
Article - 05/01/2015 Protein foils for sausages and seeds Sausage casings made of collagen can be used as an alternative to natural intestine casings as they give a similar sensation when biting into knockwursts or boiled sausages. Scientists involved in the German Federal Ministry of Education and Research funded project "Biotechnological process development for novel membranes based on collagen", are seeking to optimise the process of collagen processing using environmentally friendly…https://www.gesundheitsindustrie-bw.de/en/article/news/protein-foils-for-sausages-and-seeds
Article - 28/11/2014 Martin Plenio - turning Ulm’s quantum biology into a technology forge Quantum biology has the potential to become the next big research coup. Professor Martin Plenio, 46, director of the Institute of Theoretical Physics at Ulm University and one of the world’s leading quantum technologists, is right at the forefront. He has been Alexander von Humboldt Professor since 2009, and holds a part-time professorship at Imperial College London, where he was formerly chair of quantum physics.https://www.gesundheitsindustrie-bw.de/en/article/news/martin-plenio-turning-ulm-s-quantum-biology-into-a-technology-forge
Article - 22/07/2013 Marcus Fändrich strengthens protein biochemistry at Ulm University After quite a long vacancy the directors post of the Institute for Pharmaceutical Biotechnology at the University of Ulm has finally been filled. Marcus Fändrich and his team moved into the laboratories and offices of the new life sciences building on the Oberer Eselsberg Ulm University campus in November 2012. Fändrich fills a gap in the Ulm Bioregions biopharmaceutical education activities as he will not only be teaching biochemistry…https://www.gesundheitsindustrie-bw.de/en/article/news/marcus-faendrich-strengthens-protein-biochemistry-at-ulm-university
Article - 08/10/2012 Martin Beck and the nuclear pore atlas Dr. Martin Beck from the European Molecular Biology Laboratory in Heidelberg was awarded an ERC Starting Grant for his project “Atlas of Cell-Type Specific Nuclear Pore Complex Structures”. The combination of cryo-electron microscope tomography, proteomics and biochemical methods will enable the creation of a high-resolution three-dimensional image of the nuclear pore complex.https://www.gesundheitsindustrie-bw.de/en/article/news/martin-beck-and-the-nuclear-pore-atlas
Press release - 24/05/2012 Jiangsu Life Science and Technology Innovation Park The park is still under construction (first construction phase finished in autumn 2012). Located in Xianlin University Town, East of Nanjing Center, it is in the immediate neighborhood of the new campuses of Nanjing University, Nanjing Normal University, Nanjing University of Traditional Chinese Medicine and China Pharmaceutical University. https://www.gesundheitsindustrie-bw.de/en/article/press-release/jiangsu-life-science-and-technology-innovation-park
Article - 19/12/2011 Patrick Heun: The DNA tangle and how it is organised Dr. Patrick Heun and his group of researchers at the Max Planck Institute MPI of Immunobiology and Epigenetics in Freiburg are working on elucidating the spatial organisation of cell nuclei and how the structure of chromosomes is passed on to daughter cells during the division of cells. The researchers have come up with clear proof that the formation of centromeres depends on a single molecule. https://www.gesundheitsindustrie-bw.de/en/article/news/patrick-heun-the-dna-tangle-and-how-it-is-organised
Press release - 29/07/2011 The brain’s connectome – from branch to branch The human brain is the most complex of all organs, containing billions of neurons with their corresponding projections, all woven together in a highly complex, three-dimensional web. To date, mapping this vast network posed a practically insurmountable challenge to scientists. Now, however, a research team from the Heidelberg-based Max Planck Institute for Medical Research has developed a method for tackling the mammoth task. Using two new…https://www.gesundheitsindustrie-bw.de/en/article/press-release/the-brain-s-connectome-from-branch-to-branch
Article - 30/04/2011 The DKFZ-ZMBH Alliance The strategic alliance between the cell and tumour biology research priority at the German Cancer Research Center and the Center for Molecular Biology at Universität Heidelberg has led to the development of one of the largest centres of basic biomedical research in Germany. The top international profile of this interdisciplinary institution located at the interface between molecular and cellular biology tumour biology and biomedicine is reflected…https://www.gesundheitsindustrie-bw.de/en/article/news/the-dkfz-zmbh-alliance
Dossier - 20/12/2010 Environmental toxins: effect and origin Environmental toxins, also referred to as xenobiotics, are chemicals that do not occur in biological substance cycles; they are difficult to degrade and often have a toxic effect. Xenobiotic substances are becoming an increasing problem because we are constantly exposed to them and because they slowly but surely poison us. The World Health Organisation (WHO) sees xenobiotic substances as factors that contribute, along with other factors, to the…https://www.gesundheitsindustrie-bw.de/en/article/dossier/environmental-toxins-effect-and-origin
Article - 10/07/2010 Ulrich Schraermeyer, an eye researcher with a great deal of experience in the establishment of companies Prof. Dr. Ulrich Schraermeyer is the head of a research division at the Eye Hospital at the University of Tübingen. He focuses on the treatment of degenerative diseases such as age-dependent macular degeneration (AMD) in which he is looking for new pharmaceutically active substances. In 2001, he successfully founded a biopharmaceutical company dealing with cell therapeutics for use in ophthalmology and is now once again planning to economically…https://www.gesundheitsindustrie-bw.de/en/article/news/ulrich-schraermeyer-an-eye-researcher-with-a-great-deal-of-experience-in-the-establishment-of-compan
Article - 26/08/2009 Are fruit flies on the rise again? An inconspicuous buzzing insect – it is difficult to imagine that such a creature could be used as a model for humans. Nevertheless, since the beginning of the 20th century Drosophila melanogaster has provided us with decisive insights into human genetics, development and neurobiology. Prof. Dr. Karl-Friedrich Fischbach of the University of Freiburg has been focusing on the development and function of the fruit fly brain for several decades. What…https://www.gesundheitsindustrie-bw.de/en/article/news/are-fruit-flies-on-the-rise-again
Article - 10/06/2009 Dirk Linke - a vaccine is ready - just in case There is a well-known saying: travel broadens the mind. This is not the only consequence of travel – the biochemist Dr. Dirk Linke from Tübingen travelled to India on holiday and brought back an idea for a new scientific project. Since his return, his idea, the possibility of developing a vaccine with a wide-ranging effect against some of the most frequent diarrhoea pathogens, has even generated financial backing from prominent supporters.https://www.gesundheitsindustrie-bw.de/en/article/news/dirk-linke-a-vaccine-is-ready-just-in-case
Article - 15/05/2009 Diabetes: we cannot wait any longer, we must act now! The renowned endocrinologist Prof. Bernhard Böhm from Ulm, like many of his colleagues, is of the opinion that diabetes is a problem that concerns society as a whole. The following interview with the head of endocrinology at the University Hospital of Ulm shows why the USA invests 50 times more money into diabetes research and Böhm tells us about the three wishes he would ask of a “diabetes fairy”.https://www.gesundheitsindustrie-bw.de/en/article/news/diabetes-we-cannot-wait-any-longer-we-must-act-now
Press release - 30/04/2009 In the tubular system of human cells Scientists from the Hygiene Institute at the Heidelberg University Hospital have succeeded for the first time ever in showing the three-dimensional architecture of the dengue virus replication and assembly sites in human cells. Their paper was recently published in the renowned journal “Cell Host & Microbes”. https://www.gesundheitsindustrie-bw.de/en/article/press-release/in-the-tubular-system-of-human-cells
Article - 20/04/2009 Anita Ignatius makes biomaterials smart Anita Ignatius is not interested in knowledge just for the sake of knowledge. “I have always been interested in the practical application of knowledge,” said the 45-year-old veterinarian. Highly theoretical courses she had to attend during her studies put an end to her dreams of opening her own practice after university. But this experience also had its advantages, because it helped her realise what she really wanted – namely doing research of…https://www.gesundheitsindustrie-bw.de/en/article/news/anita-ignatius-makes-biomaterials-smart
Article - 07/04/2009 Hendrik Küpper – at the service of plants and humans Prof. Hendrik Küpper had his first experience as a scientist in 1992 when together with his brother and a friend he participated in the German governments Jugend forscht contest. The students came first in biology in the national competition and first in both the Young Europeans Environmental Research Contest and the European Community Contest for Young Scientists. Back then Küpper was already interested in the interaction between heavy metals…https://www.gesundheitsindustrie-bw.de/en/article/news/hendrik-kuepper-at-the-service-of-plants-and-humans
Press release - 08/01/2009 ILM – Laser-assisted preventive and curative dental treatment In cooperation with numerous industrial partners and with the support of public funds, researchers at the ILM are focusing on the optimisation of sealer materials and remineralisation substances as well as on effective and permanent preventive caries treatment. https://www.gesundheitsindustrie-bw.de/en/article/press-release/ilm-laser-assisted-preventive-and-curative-dental-treatment
Article - 27/10/2008 What determines the shape of neuronal contact sites? Tobias M. Boeckers an anatomist at the University of Ulm works on an important aspect of basic neurobiological research - the transmission of signals between nerve cells. Two years ago his findings suddenly began to be seen in a different light and became important for clinical research.https://www.gesundheitsindustrie-bw.de/en/article/news/what-determines-the-shape-of-neuronal-contact-sites
Article - 12/05/2008 Heat to combat house dust mites As many as four to five million people in Germany suffer from house dust mite allergy. Researchers from the Hohenstein Institutes have now developed a mattress that promises relief for these people. The entire mattress is heated by way of flexible textile heating elements.https://www.gesundheitsindustrie-bw.de/en/article/news/heat-to-combat-house-dust-mites
Article - 10/05/2008 New analysis system developed Researchers have developed a method that enables them to culture lymphatic vessels under laboratory conditions. The goal of the project is to gain a better understanding of how new lymphatic vessels are formed a process known as lymphangiogenesis.https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-analysis-system-developed
Article - 20/02/2008 Threadworms throughout time Threadworms are versatile research objects and are excellent models for investigating fundamental evolutionary principles. Researchers at the Max Planck Institute for Developmental Biology use the Caenorhabditis and Pristionchus threadworm genera to study the molecular mechanisms of biodiversity.https://www.gesundheitsindustrie-bw.de/en/article/news/threadworms-throughout-time